Alebund Pharmaceuticals' (HKG:9637) Hong Kong-listed shares have been included in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs effective Monday.
The company believes its inclusion in the cross-border trading links will help broaden its investor base and boost the trading liquidity of its shares, according to a Monday bourse filing.